Clinical Trial: Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis

Brief Summary: Randomized, double-blind, placebo controlled study evaluating the efficacy of certolizumab pegol in the treatment of interstitial cystitis/ bladder pain syndrome.